The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

sonitusmedical.com

Founded Year

2006

Stage

Dead | Dead

Total Raised

$89.72M

About Sonitus Medical

Sonitus Medical is a medical device company committed to providing advanced hearing solutions that hearing professionals such as Otologists, ENTs, and Audiologists can use to help their patients rejoin the conversation of life. The company's SoundBite Hearing System is a non-surgical and removable hearing solution that imperceptibly transmits sound via the teeth. Relying on the well-established principle of bone conduction, the nearly invisible ITM (In-The-Mouth) device is a simple and non-invasive hearing and communication platform. Currently FDA cleared for the treatment of Single Sided Deafness and Conductive Hearing Loss, the SoundBite system has intended future indications for hearing disorders such as mixed hearing loss and tinnitus, as well as consumer and covert communications.

Sonitus Medical Headquarter Location

1900 Alameda De Las Pulgas Suite 200

San Mateo, California, 94403,

United States

866-816-2076

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sonitus Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sonitus Medical is included in 1 Expert Collection, including Digital Health.

D

Digital Health

12,785 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Sonitus Medical Patents

Sonitus Medical has filed 58 patents.

The 3 most popular patent topics include:

  • Audiology
  • Auditory system
  • Ear
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/20/2018

3/22/2022

Auditory system, Hearing aids, Ear, Audiology, Hearing aid manufacturers

Grant

Application Date

9/20/2018

Grant Date

3/22/2022

Title

Related Topics

Auditory system, Hearing aids, Ear, Audiology, Hearing aid manufacturers

Status

Grant

Latest Sonitus Medical News

iT2, a New Global Wearable Communication Technology Company, Launches via Acquisition of Sonitus Technologies and Partnership With Apparel and Wearable Solutions Provider Bluewater Defense

Oct 5, 2021

Vision is to ‘extend the utility of apparel beyond mere clothing’ October 05, 2021 09:00 AM Eastern Daylight Time SAN MATEO, Calif.--( BUSINESS WIRE )--Uniting proven miniaturized personal communications technologies gained through the acquisition of Sonitus Technologies with the garment manufacturing expertise and supply chain of Bluewater Defense, Integrated Tactical Technologies (“iT2”) has been formed to develop unified personal communications based wearable solutions for defense, commercial, and consumer markets that extend the utility of apparel beyond mere clothing. Core to this vision is a highly reliable, discreet, and secure wireless personal communications platform developed by Sonitus Technologies. This proprietary platform features a sophisticated body sensing capability and encrypted wireless network that seamlessly links communication and biometric data with existing communication infrastructure and devices. A proven DOD provider that recognized the need for new human-machine interfaces nearly a decade ago, Sonitus Technologies started designing a solution leveraging advanced hearing aid technology first developed by serial entrepreneur Amir Abolfathi in his initial company Sonitus Medical. That technology was later spun out into Sonitus Technologies led by CEO Peter Hadrovic. Under Mr. Hadrovic, Sonitus Technologies further developed the hearing aid technology into a proprietary communications platform, forming strategic partnerships with government customers and seasoned industry partners, all with the vision of accelerating and expanding the reach of the novel communications platform. The formation of iT2 combines Sonitus Technologies’ unique domain expertise, intellectual property, communications platform, standing contracts, and customer relationships with Bluewater Defense’s garment manufacturing, textile product development, and supply chain expertise. This uniquely positions iT2 to bring next generation wearable communications technology to new markets. Terms of the transaction were not disclosed. Early Investors and partners in Sonitus Technologies were In-Q-Tel, Panasonic, KCK, and the Defense Innovation Unit of the DOD. “We see ourselves as a startup on steroids, leveraging the incredible technology developed by the founders and team at Sonitus Technologies,” said Eric Spackey, Chairman and Co-Founder of iT2 and CEO of Bluewater Defense. “We all increasingly interact with more and more digital machines, not merely to get more things done but to efficiently extend human capacity and potential in all aspects of our lives. To optimize this moment, we need better human-machine interfaces and iT2 is ideally positioned to meet that need. Our established end-to-end global capabilities exemplify our abilities to innovate and execute,” Spackey continued. Rethinking Human and Machine Interfaces Interfaces to date have been application specific, singularly focused, and unintelligent. Examples are haptics/touch systems for typing on keyboards, tapping out instructions on smartphones, tablets, and watches, and for unlocking our cars; and voice for talking into phones and more recently for requesting information from services like Alexa; and immersive, attention demanding “heads-down” screen based visual displays such as those used in popular online games. “An entirely new approach is needed,” said Spackey. He added that iT2 will focus on a new human and machine interface that is: intrinsically part of the user and the user experience multi-modal, capable of serving numerous vital purposes extendable and compatible with existing systems intelligent, secure, and reliable in any scenario producible in quantities great enough to make them commercially viable “Our solution will be like a sixth sense, a second skin, like night vision for your ears,” he added. “More importantly, it will serve as a sensory platform that will support new applications and technologies as they become available in the years to come.” iT2 will honor existing contracts and continue to support current Sonitus Technologies customers and partners with “bolt on” innovations and new solutions through channel partners to extend market reach. The Sonitus Technologies flagship product was Molar Mic™, a miniaturized module that fits comfortably in a user’s mouth and can accommodate sensors for a range of real-time applications, from two-way personal communications to biometrics. This wireless two-way communications system snaps onto a user’s back teeth and enables them to communicate clearly and securely with any device in even the harshest conditions. “Molar Mic is a unique communications device that combines a hearable that requires no additional equipment in or on the ears and a microphone that captures speech from inside your mouth – in even the harshest conditions – all rolled together,” said Hadrovic, CEO of iT2 and formerly the CEO of Sonitus Technologies. “This is just the start. Molar Mic is part of an on-body wireless communication and sensing system that will serve as a platform upon which we will fill gaps that previously could not be addressed by conventional wearables.” Ensuring Commercial Viability A major challenge facing new entrants in the wearables market has been the inability to produce new solutions in quantities great enough to achieve commercial viability. iT2 addressed this challenge from the get-go through a manufacturing partnership with Bluewater Defense. Bluewater Defense is a trusted provider of innovative apparel and functional fabric solutions specifically designed to enhance human capacity in the most demanding military, industrial, and commercial environments. A trusted provider for more than 30 years to a wide range of customers within the DOD, Bluewater has proven expertise in advanced apparel manufacturing utilizing increasingly dynamic fabrics and wearable technologies. Bluewater also is a premier partner in alternative materials research, manufacturing best practices, and sustainability projects with Advanced Functional Fabrics of America at MIT, Carnegie Mellon University, the University of Georgia, Lincoln Labs, and other industry leaders. About iT2 iT2 is a global wearable technologies company that is marrying advanced fabric and apparel design with miniaturized personal communications technologies to produce a novel line of wearable solutions based on an entirely new human-machine sensory interface. For more information, visit iT2 . Contacts

You May Also Like

Endologix Logo
Endologix

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. Endologix is currently marketing its Powerlink Delivery System a, one-piece endoluminal stent graft (ELG) used in treating AAA that has significant advantages when compared with marketed stent alternatives. Powerlink has been commercially available in Europe since 1999. FDA approval for the Powerlink AAA stent graft was received on October 29, 2004. The Powerlink superior design is covered by 17 U.S. patents with 361 allowed claims; the technology is designed to overcome shortcomings of first-generation ELGs. The device is for sale in the United States and selected international markets. Endologix is a publicly-held company trading on NASDAQ: ELGX. The company's corporate office is located in Irvine, California.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

V
Varix Medical

Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.

O
OtoKinetics

Otokinetics has been formed to create and promulgate an entirely new product category in hearing aid devices.

C
CryoPen

CryoPen is a developer and manufacturer of state-of-the art medical devices and aesthetic treatment systems. CryoPen is committed to delivering the most effective, and profitable solutions available to healthcare providers, physicians of all specialties, and medical spas. The company's product portfolio aims to enable physicians to provide a higher quality of care and offer their patients a more diverse array of treatments while generating a substantial revenue stream for their practice. CryoPen's product set addresses a multitude of treatment applications such as laser hair removal, skin rejuvenation, cryosurgery, cellulite reduction, vascular lesions, pigmented lesions, acne, psoriasis, fine lines & wrinkles, scar and tattoo removal, photo facials, and skin tightening. With a dedication to the research and development of technologically advanced devices and equipment, every CryoPen product is designed to create a better patient experience, consistent clinical outcomes, and economic impact on the bottom line of their practice.

N
NeuroTrax

NeuroTrax is a medical device and technology company.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.